Lynparza Phase III PAOLA-1 trial met primary endpoint as 1st-line maintenance treatment with bevacizumab for advanced ovarian cancer

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced positive results from the Phase III PAOLA-1 trial in women with advanced ovarian cancer. The trial, in the 1st-line maintenance setting, compared Lynparza (olaparib) added to standard-of-care (SoC) bevacizumab vs. bevacizumab alone in women […]

Continue Reading

Health Tip: Using Aloe Vera

News Consumer News Health Tip: Using Aloe Vera — Aloe vera is a plant that has been widely used for its healing abilities, the U.S. National Center for Complementary and Integrative Health says. Topical aloe vera is likely to be safe and helpful for psoriasis and certain skin rashes, the center says. But the center […]

Continue Reading